ArticleCureus2025
Necrotizing Sarcoid Granulomatosis: Another Great Imitator.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis with a necrotizing sarcoid granulomatosis (NSG) pattern is a rare disease that shares similar findings with sarcoidosis and is considered a distinct variant. However, the histological presence of necrosis may lead to misdiagnosis and a delay in treatment. We report the case of a 56-year-old Caucasian woman with cough, fatigue, dyspnea with lymphadenopathy, and consolidations on a CT scan. Histological examinations and a wide spectrum of diagnostic investigations, which excluded other infectious and non-infectious causes as well as malignancy, confirmed the diagnosis of sarcoidosis with an NSG pattern. Treatment with corticosteroids initially led to the regression of symptoms. However, the treatment had to be discontinued after a manifestation of corticosteroid-induced psychosis. The reintroduction of corticosteroids at a reduced dose was well tolerated and resulted in a good clinical and imaging response. Sarcoidosis with an NSG pattern must be distinguished from other systemic and infectious diseases. As emphasized in this report, a rigorous diagnostic workup is mandatory to establish the diagnosis. Although corticosteroids are considered the treatment of choice, possible side effects and dosage adjustments should be evaluated regularly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.